Mog1p Activators
Mog1p Activators are a class of chemical compounds that specifically enhance the functional activity of Mog1p, a crucial protein involved in the nucleocytoplasmic transport. Several compounds that participate in or influence this process can logically serve as Mog1p activators. For instance, Guanosine Triphosphate (GTP), Guanosine Diphosphate (GDP), Phosphatidylinositol 4,5-bisphosphate (PIP2), Inositol trisphosphate (IP3), Diacylglycerol (DAG), and Ca2+ Ionophore A23187 are compounds that directly participate in the cellular processes where Mog1p operates. GTP and GDP are integral to the functionof Mog1p in the GTPase cycle, playing direct roles in its activation and transition states. PIP2, IP3, and DAG, on the other hand, are involved in second messenger signaling, influencing nuclear envelope permeability, which is crucial for Mog1p's role in nucleocytoplasmic transport. Ca2+ Ionophore A23187 also influences this process by increasing cytosolic calcium concentration, thereby enhancing nuclear envelope permeability.
Additionally, certain compounds that act on kinases or increase the levels of cyclic adenosine monophosphate (cAMP) can indirectly enhance Mog1p activity. Phorbol 12-myristate 13-acetate (PMA), Forskolin, 8-Bromo-cAMP, and N6,2'-O-Dibutyryladenosine 3',5'-cyclic monophosphate (db-cAMP) are such compounds. PMA and Forskolin act on protein kinase C (PKC) and adenylate cyclase, respectively, influencing the phosphorylation state of proteins involved in nucleocytoplasmic transport, thereby potentially enhancing Mog1p function. 8-Bromo-cAMP and db-cAMP, being cell-permeable cAMP analogs, can increase Protein Kinase A (PKA) activity, further modulating the phosphorylation state of proteins, indirectly leading to the activation of Mog1p. Caffeine, a phosphodiesterase inhibitor, and Calmodulin, a calcium-binding messenger protein, also have the potential to act as Mog1p activators by influencing cAMP levels and nuclear envelope permeability, respectively.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guanosine 5′-Triphosphate, Disodium Salt | 56001-37-7 | sc-295030 sc-295030A | 50 mg 250 mg | $166.00 $327.00 | ||
GTP is a purine nucleotide that is integral to signal transduction in the GTPase cycle. Mog1p, being a Ran GTPase-activating protein, is activated when GTP binds to Ran, triggering the release of the bound GDP. Hence, GTP availability can directly enhance Mog1p activity. | ||||||
Guanosine 5′-diphosphate disodium salt | 7415-69-2 | sc-211574 sc-211574A | 100 mg 500 mg | $206.00 $698.00 | ||
GDP is a purine nucleotide involved in energy transfer. It binds to Ran in the inactive state. The higher availability of GDP can activate Mog1p by facilitating the transition from the GTP-bound state to the GDP-bound state. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DAG is a second messenger that activates protein kinase C. Enhanced PKC activity could influence the phosphorylation state of proteins involved in the nucleocytoplasmic transport, potentially enhancing the function of Mog1p. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Ca2+ Ionophore A23187 is a mobile ion carrier that forms a stable complex with calcium. The increased cytosolic calcium concentration can enhance the nuclear envelope permeability, thus indirectly enhancing the function of Mog1p in nucleocytoplasmic transport. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator. Enhanced PKC activity could influence the phosphorylation state of proteins involved in the nucleocytoplasmic transport, potentially enhancing the function of Mog1p. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. This could influence PKA activity and thereby the phosphorylation state of proteins involved in the nucleocytoplasmic transport, potentially enhancing the function of Mog1p. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog. Increased cAMP can influence PKA activity and thereby the phosphorylation state of proteins involved in the nucleocytoplasmic transport, potentially enhancing the function of Mog1p. | ||||||
Calmodulin (human), (recombinant) | 73298-54-1 | sc-471287 | 1 mg | $300.00 | ||
Calmodulin is a calcium-binding messenger protein expressed in all eukaryotic cells. It can enhance the nuclear envelope permeability, thus indirectly enhancing the function of Mog1p in nucleocytoplasmic transport. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine is a known phosphodiesterase inhibitor, thus can increase cAMP levels which could influence PKA activity and thereby the phosphorylation state of proteins involved in the nucleocytoplasmic transport, potentially enhancing the function of Mog1p. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog. Increased cAMP can influence PKA activity and thereby the phosphorylation state of proteins involved in the nucleocytoplasmic transport, potentially enhancing the function of Mog1p. | ||||||